Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

THW vs CCD: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

THW Captures Overall Composite Edge (36.7 SELL vs 40.6 SELL), While CCD Leads 1–0 on Growth & Valuation Pillars

THW Overall Winner 6-Pillar Tally: THW 0 – 1 CCD (5 Tie) Matrix Metrics: THW 2 – 2 CCD

As of Nov 16, 2026, abrdn World Healthcare Fund (THW) captures the overall head-to-head institutional edge over Calamos Dynamic Convertible & Income Fund (CCD) on higher Unified Composite conviction (36.7/100 SELL vs. 40.6/100 SELL) after splitting the core matrix 2–2 (led by composite factor balance), while CCD wins 1–0 across the 6-pillar growth and valuation breakdown. THW trades at $12.91 (N/M Forward P/E, N/A operating margin) versus CCD at $19.31 (N/M Forward P/E, N/A operating margin).

  • Composite vs. Pillar Nuance: While CCD currently prints a higher short-term Unified Composite Score (40.6/100 SELL vs. THW 36.7/100 SELL), THW captures the overall institutional head-to-head verdict (2–2 matrix metrics and 0–1 across the 6 pillars) due to superior fundamental profitability (N/A vs. N/A operating margin) and revenue trajectory (N/A vs. N/A YoY).
  • Defensive Composite Rating Caution: Although THW compares more favorably head-to-head, both THW (36.7/100 SELL) and CCD (40.6/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
  • Technical & Structure Timing Caution: THW is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 49.4); meanwhile CCD is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 28.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About THW vs CCD
THW NYSE Head-to-Head Winner
abrdn World Healthcare Fund
Institutional Equity
$12.91
-1.71% 1D
Market Cap $510.6M
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.71β · 27% Vol
Unified Composite Score
36.7 / 100 SELL
Tech 34.0 Fund 42.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Distribution · Trim / tighten stop
Price near a flattening SMA50 (slope -3.5%) with fading momentum, RSI 49
RSI-14: 49.4 · SMA20: $12.87 · SMA50: $12.89
CCD NASDAQ
Calamos Dynamic Convertible & Income Fund
Institutional Equity
$19.31
-3.74% 1D
Market Cap $568.7M
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 1.31β · 30% Vol
Unified Composite Score
40.6 / 100 SELL
Tech 32.0 Fund 48.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -6.8%), weak momentum, RSI 29
RSI-14: 28.8 · SMA20: $21.16 · SMA50: $22.48

6-Pillar Scorecard Institutional Category Breakdown (THW 0 – 1 CCD)

Columns: Metric · THW · CCD
1. Valuation Multiples Tie
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue N/M N/M
2. Growth & Scale CCD
Revenue Growth (YoY) N/A N/A
Earnings Growth (YoY) N/A N/A
TTM Revenue (USD) N/A N/A
Market Cap $510.6M $568.7M
3. Profitability & Quality Tie
Gross Margin N/A N/A
Operating Margin N/A N/A
Net Profit Margin N/A N/A
Return on Equity (ROE) N/A N/A
4. Balance Sheet & Cash Flow Tie
Cash Generation (TTM) N/A N/A
Cash Flow Margin N/A N/A
Net Cash / Leverage N/A ROE N/A ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Distribution NEUTRAL · Markdown
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Institutional Equity Operator Institutional Equity Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: THW (2) vs CCD (2)
Institutional Metric THW CCD Criterion Row Edge
Market Capitalization
Scale
$510.6M $568.7M Larger Scale CCD
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
N/A N/A Higher Growth Tie
Operating Margin (TTM)
Profitability
N/A N/A Higher Margin Tie
Net Profit Margin
Profitability
N/A N/A Higher Margin Tie
Return on Equity (ROE)
Capital Efficiency
N/A N/A Higher ROE Tie
52-Week Range Position
Momentum
52% ($11–$14) 0% ($19–$27) Stronger Trend THW
Beta / 30D Volatility
Risk Regime
0.71β · 27% Vol 1.31β · 30% Vol Lower Realized Risk THW
Unified Institutional Score
Composite Signal
36.7 / 100 (SELL) 40.6 / 100 (SELL) Higher Composite CCD
Trailing 12M Revenue (USD)
Operating Scale
N/A N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (N/A ROE) N/A (N/A ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon THW +19.56 pp
THW: +6.82% · CCD: -12.74%
3M Horizon THW +16.53 pp
THW: -8.66% · CCD: -25.19%
6M Horizon THW +19.06 pp
THW: +0.98% · CCD: -18.08%
1Y Horizon THW +11.47 pp
THW: +2.3% · CCD: -9.17%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on THW vs CCD. Trailing 12-month operating profitability (THW N/A vs CCD N/A) and valuation multiples (THW N/M vs CCD N/M Forward P/E) are benchmarked directly in Pillar 4 below.

THW ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M
CCD ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
THW UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact THW Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
CCD UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact CCD Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
THW Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with $510.6M market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
CCD Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with $568.7M market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ THW vs CCD Key Questions & Quantitative Answers

As of Nov 16, 2026, abrdn World Healthcare Fund (THW) captures the overall head-to-head institutional edge over Calamos Dynamic Convertible & Income Fund (CCD) on higher Unified Composite conviction (36.7/100 SELL vs. 40.6/100 SELL) after splitting the core matrix 2–2 (led by composite factor balance), while CCD wins 1–0 across the 6-pillar growth and valuation breakdown. THW trades at $12.91 (N/M Forward P/E, N/A operating margin) versus CCD at $19.31 (N/M Forward P/E, N/A operating margin). Composite vs. Pillar Nuance: While CCD currently prints a higher short-term Unified Composite Score (40.6/100 SELL vs. THW 36.7/100 SELL), THW captures the overall institutional head-to-head verdict (2–2 matrix metrics and 0–1 across the 6 pillars) due to superior fundamental profitability (N/A vs. N/A operating margin) and revenue trajectory (N/A vs. N/A YoY). Defensive Composite Rating Caution: Although THW compares more favorably head-to-head, both THW (36.7/100 SELL) and CCD (40.6/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model. Technical & Structure Timing Caution: THW is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 49.4); meanwhile CCD is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 28.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

CCD leads the Growth & Scale pillar: THW posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with CCD at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, THW generates N/A in USD-normalized revenue versus N/A for CCD. In operating R&D and SG&A reinvestment, THW deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for CCD.

THW and CCD trade at balanced relative valuation multiples. THW trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas CCD trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against THW (N/A ROE) versus CCD (N/A ROE) capital efficiency.

In options market volatility and institutional positioning, THW carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.71β · 27% Vol realized risk). By comparison, CCD carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.31β · 30% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.